These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Vallières E, Wood DE. J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298 [Abstract] [Full Text] [Related]
6. 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer. Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Mori M, Endo K. J Nucl Med; 2009 Nov; 50(11):1770-6. PubMed ID: 19837768 [Abstract] [Full Text] [Related]
7. Correlation of ¹⁸F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Han B, Lin S, Yu LJ, Wang RZ, Wang YY. Nucl Med Commun; 2009 Nov; 30(11):831-7. PubMed ID: 19734817 [Abstract] [Full Text] [Related]
8. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer]. Zhao SJ, Wu N, Zheng R, Liu Y, Zhang WJ, Liang Y, Zhang H, Li XM. Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097 [Abstract] [Full Text] [Related]
9. The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers. Apostolova I, Ego K, Steffen IG, Buchert R, Wertzel H, Achenbach HJ, Riedel S, Schreiber J, Schultz M, Furth C, Derlin T, Amthauer H, Hofheinz F, Kalinski T. Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2360-2373. PubMed ID: 27470327 [Abstract] [Full Text] [Related]
10. [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R. ORL J Otorhinolaryngol Relat Spec; 2001 Dec; 63(5):307-13. PubMed ID: 11528276 [Abstract] [Full Text] [Related]
11. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study. Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I, Ménard JF, Modzelewski R, Thiberville L, Dubray B. Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487 [Abstract] [Full Text] [Related]
12. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Nguyen XC, Lee WW, Chung JH, Park SY, Sung SW, Kim YK, So Y, Lee DS, Chung JK, Lee MC, Kim SE. Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556 [Abstract] [Full Text] [Related]
13. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML. Radiat Oncol; 2017 Jan 05; 12(1):4. PubMed ID: 28057034 [Abstract] [Full Text] [Related]
14. Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma. Schuurbiers OC, Meijer TW, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, van der Drift MA, van der Heijden EH, Oyen WJ, Visser EP, Span PN, Bussink J. J Thorac Oncol; 2014 Oct 05; 9(10):1485-93. PubMed ID: 25170642 [Abstract] [Full Text] [Related]
15. Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients? Choi WH, Yoo IeR, O JH, Kim TJ, Lee KY, Kim YK. Technol Health Care; 2015 Oct 05; 23 Suppl 2():S311-8. PubMed ID: 26410497 [Abstract] [Full Text] [Related]
16. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers. Nakamura H, Hirata T, Kitamura H, Nishikawa J. Ann Thorac Cardiovasc Surg; 2009 Oct 05; 15(5):304-10. PubMed ID: 19901884 [Abstract] [Full Text] [Related]
17. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Eur J Nucl Med Mol Imaging; 2015 Aug 05; 42(9):1353-61. PubMed ID: 26067088 [Abstract] [Full Text] [Related]
18. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S. Eur J Cardiothorac Surg; 2013 Jul 05; 44(1):83-7. PubMed ID: 23233074 [Abstract] [Full Text] [Related]
19. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma? Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S. Ann Nucl Med; 2015 Dec 05; 29(10):897-905. PubMed ID: 26342592 [Abstract] [Full Text] [Related]
20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan 05; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]